6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Nicotine
Nicotine is a natural alkaloid found in tobacco that belongs to the nightshade family of plants and is commonly used as a stimulant and anxiolytic. Nicotine is used medically to help people quit smoking during withdrawal. Nicotine is extremely addicting and should only be used in slow-release form. Tobacco smoke contains monoamine oxidase inhibitors, which may intensify nicotine's addictive characteristics. A typical cigarette contains nearly 2 mg of nicotine. Nicotine addiction is characterised by obsessive usage, drug-reinforced behaviour, and relapse. Tolerance, sensitization, physical dependency, and psychological dependence can all lead to distress. Nicotine withdrawal symptoms include difficulties concentrating, sleep disruptions, depression, tension, anxiety, and irritability.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States